Skip to main content
SpringerLink
Log in

Clinical Applications of Nuclear Cardiology

  • Chapter
  • First Online:
Clinical Nuclear Medicine

  • 1435 Accesses

Abstract

Nuclear cardiology has continued to expand its already established role in the evaluation of cardiac patients with advances in hardware, software, new radiotracers, and clinical indications. These advances include high temporal and spatial resolution SPECT and PET cameras, hybrid imaging with computed tomography (CT) or magnetic resonance imaging (MRI), and high-sensitivity detectors and new radiotracers that allow not only the evaluation of myocardial perfusion, viability, and function but also risk stratification for sudden death and the characterization of myocardial and vascular inflammation. This chapter will focus on the clinical applications of nuclear cardiology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol. 2003;42(7):1318–33.

    PubMed  Google Scholar 

  2. Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. 2016;23(3):606–39.

    PubMed  Google Scholar 

  3. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23(5):1187–226.

    PubMed  Google Scholar 

  4. Schelbert HR. Anatomy and physiology of coronary blood flow. J Nucl Cardiol. 2010;17(4):545–54.

    PubMed  PubMed Central  Google Scholar 

  5. Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, De Bondt P, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging. 2015;42(12):1929–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Sogbein OO, Pelletier-Galarneau M, Schindler TH, Wei L, Wells RG, Ruddy TD. New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. Biomed Res Int. 2014;2014:942960.

    PubMed  PubMed Central  Google Scholar 

  7. Udelson JE, Bonow RO, Dilsizian V. The historical and conceptual evolution of radionuclide assessment of myocardial viability. J Nucl Cardiol. 2004;11(3):318–34.

    PubMed  Google Scholar 

  8. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117(1):103–14.

    PubMed  Google Scholar 

  9. Thompson RC, Heller GV, Johnson LL, Case JA, Cullom SJ, Garcia EV, et al. Value of attenuation correction on ECG-gated SPECT myocardial perfusion imaging related to body mass index. J Nucl Cardiol. 2005;12(2):195–202.

    PubMed  Google Scholar 

  10. Johnson LL, Verdesca SA, Aude WY, Xavier RC, Nott LT, Campanella MW, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol. 1997;30(7):1641–8.

    CAS  PubMed  Google Scholar 

  11. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med. 2001;42(6):831–7.

    CAS  PubMed  Google Scholar 

  12. Mathur S, Heller GV, Bateman TM, Ruffin R, Yekta A, Katten D, et al. Clinical value of stress-only Tc-99m SPECT imaging: importance of attenuation correction. J Nucl Cardiol. 2013;20(1):27–37.

    PubMed  Google Scholar 

  13. Ferreira MJ, Cunha MJ, Albuquerque A, Moreira AP, Ramos D, Costa G, et al. Prognosis of normal stress-only gated-SPECT myocardial perfusion imaging: a single center study. Int J Cardiovasc Imaging. 2013;29(7):1639–44.

    PubMed  Google Scholar 

  14. Gowd BM, Heller GV, Parker MW. Stress-only SPECT myocardial perfusion imaging: a review. J Nucl Cardiol. 2014;21(6):1200–12.

    PubMed  Google Scholar 

  15. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 1993;87(1):1–20.

    CAS  PubMed  Google Scholar 

  16. Dilsizian V. Transition from SPECT to PET myocardial perfusion imaging: a desirable change in nuclear cardiology to approach perfection. J Nucl Cardiol. 2016;23(3):337–8.

    PubMed  Google Scholar 

  17. Bateman TM. Advantages and disadvantages of PET and SPECT in a busy clinical practice. J Nucl Cardiol. 2012;19(Suppl 1):S3–11.

    PubMed  Google Scholar 

  18. Stabin MG. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk. J Nucl Med. 2008;49(9):1555–63.

    CAS  PubMed  Google Scholar 

  19. Maddahi J, Packard RR. Cardiac PET perfusion tracers: current status and future directions. Semin Nucl Med. 2014;44(5):333–43.

    PubMed  PubMed Central  Google Scholar 

  20. Nakazato R, Berman DS, Alexanderson E, Slomka P. Myocardial perfusion imaging with PET. Imaging Med. 2013;5(1):35–46.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Cerqueira MD. Pharmacologic stress versus maximal-exercise stress for perfusion imaging: which, when, and why? J Nucl Cardiol. 1996;3(6 Pt 2):S10–4.

    CAS  PubMed  Google Scholar 

  22. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol. 1989;14(6):1477–86.

    CAS  PubMed  Google Scholar 

  23. Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004;94(2A):33D–40D. discussion D-2D

    CAS  PubMed  Google Scholar 

  24. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan multicenter trial registry. J Am Coll Cardiol. 1994;23(2):384–9.

    CAS  PubMed  Google Scholar 

  25. Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous dipyridamole thallium imaging study group. Circulation. 1990;81(4):1205–9.

    CAS  PubMed  Google Scholar 

  26. Mahmarian JJ, Cerqueira MD, Iskandrian AE, Bateman TM, Thomas GS, Hendel RC, et al. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. J Am Coll Cardiol Img. 2009;2(8):959–68.

    Google Scholar 

  27. Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo JA, Blackburn B, et al. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;46(11):2069–75.

    CAS  PubMed  Google Scholar 

  28. Al Jaroudi W, Iskandrian AE. Regadenoson: a new myocardial stress agent. J Am Coll Cardiol. 2009;54(13):1123–30.

    PubMed  Google Scholar 

  29. Lette J, Tatum J, Fraser S, Miller D, Waters D, Heller G, et al. Safety of dipyridamole testing in 73,806 patients: the multicenter dipyridamole safety study. J Nucl Cardiol. 1995;2(1):3–17.

    CAS  PubMed  Google Scholar 

  30. Leppo JA. Comparison of pharmacologic stress agents. J Nucl Cardiol. 1996;3(6 Pt 2):S22–6.

    CAS  PubMed  Google Scholar 

  31. American Society of Nuclear Cardiology. Updated imaging guidelines for nuclear cardiology procedures, part 1. J Nucl Cardiol. 2001;8(1):G5–G58.

    Google Scholar 

  32. Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol. 1993;21(7):1583–90.

    CAS  PubMed  Google Scholar 

  33. Agostini D, Marie PY, Ben-Haim S, Rouzet F, Songy B, Giordano A, et al. Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging. 2016;43(13):2423–32.

    CAS  PubMed  Google Scholar 

  34. Nudi F, Iskandrian AE, Schillaci O, Peruzzi M, Frati G, Biondi-Zoccai G. Diagnostic accuracy of myocardial perfusion imaging with CZT technology: systemic review and meta-analysis of comparison with invasive coronary angiography. J Am Coll Cardiol Img. 2017;10(7):787–94.

    Google Scholar 

  35. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36(11):2138–47.

    CAS  PubMed  Google Scholar 

  36. Akincioglu C, Berman DS, Nishina H, Kavanagh PB, Slomka PJ, Abidov A, et al. Assessment of diastolic function using 16-frame 99mTc-sestamibi gated myocardial perfusion SPECT: normal values. J Nucl Med. 2005;46(7):1102–8.

    PubMed  Google Scholar 

  37. Choi JY, Lee KH, Kim SJ, Kim SE, Kim BT, Lee SH, et al. Gating provides improved accuracy for differentiating artifacts from true lesions in equivocal fixed defects on technetium 99m tetrofosmin perfusion SPECT. J Nucl Cardiol. 1998;5(4):395–401.

    CAS  PubMed  Google Scholar 

  38. Everaert H, Franken PR, Flamen P, Goris M, Momen A, Bossuyt A. Left ventricular ejection fraction from gated SPET myocardial perfusion studies: a method based on the radial distribution of count rate density across the myocardial wall. Eur J Nucl Med. 1996;23(12):1628–33.

    CAS  PubMed  Google Scholar 

  39. Everaert H, Vanhove C, Franken PR. Gated SPET myocardial perfusion acquisition within 5 minutes using focussing collimators and a three-head gamma camera. Eur J Nucl Med. 1998;25(6):587–93.

    CAS  PubMed  Google Scholar 

  40. Gunning MG, Anagnostopoulos C, Davies G, Forbat SM, Ell PJ, Underwood SR. Gated technetium-99m-tetrofosmin SPECT and cine MRI to assess left ventricular contraction. J Nucl Med. 1997;38(3):438–42.

    CAS  PubMed  Google Scholar 

  41. Mochizuki T, Murase K, Tanaka H, Kondoh T, Hamamoto K, Tauxe WN. Assessment of left ventricular volume using ECG-gated SPECT with technetium-99m-MIBI and technetium-99m-tetrofosmin. J Nucl Med. 1997;38(1):53–7.

    CAS  PubMed  Google Scholar 

  42. Slomka PJ, Berman DS, Xu Y, Kavanagh P, Hayes SW, Dorbala S, et al. Fully automated wall motion and thickening scoring system for myocardial perfusion SPECT: method development and validation in large population. J Nucl Cardiol. 2012;19(2):291–302.

    PubMed  PubMed Central  Google Scholar 

  43. Abidov A, Germano G, Hachamovitch R, Slomka P, Berman DS. Gated SPECT in assessment of regional and global left ventricular function: an update. J Nucl Cardiol. 2013;20(6):1118–43. quiz 44-6

    PubMed  Google Scholar 

  44. Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54(8):1485–507.

    PubMed  Google Scholar 

  45. Gaemperli O, Kaufmann PA, Alkadhi H. Cardiac hybrid imaging. Eur J Nucl Med Mol Imaging. 2014;41(Suppl 1):S91–103.

    PubMed  Google Scholar 

  46. Schaap J, de Groot JA, Nieman K, Meijboom WB, Boekholdt SM, Kauling RM, et al. Added value of hybrid myocardial perfusion SPECT and CT coronary angiography in the diagnosis of coronary artery disease. Eur Heart J Cardiovasc Imaging. 2014;15(11):1281–8.

    PubMed  Google Scholar 

  47. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging Committee of the Council on clinical cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002;18(1):539–42.

    PubMed  Google Scholar 

  48. Xu Y, Kavanagh P, Fish M, Gerlach J, Ramesh A, Lemley M, et al. Automated quality control for segmentation of myocardial perfusion SPECT. J Nucl Med. 2009;50(9):1418–26.

    PubMed  PubMed Central  Google Scholar 

  49. Slomka PJ, Nishina H, Berman DS, Akincioglu C, Abidov A, Friedman JD, et al. Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol. 2005;12(1):66–77.

    PubMed  Google Scholar 

  50. Slomka P, Xu Y, Berman D, Germano G. Quantitative analysis of perfusion studies: strengths and pitfalls. J Nucl Cardiol. 2012;19(2):338–46.

    PubMed  PubMed Central  Google Scholar 

  51. Ziadi MC. Myocardial flow reserve (MFR) with positron emission tomography (PET)/computed tomography (CT): clinical impact in diagnosis and prognosis. Cardiovasc diagn Ther. 2017;7(2):206–18.

    PubMed  PubMed Central  Google Scholar 

  52. Cerqueira MD. The user-friendly nuclear cardiology report: what needs to be considered and what is included. J Nucl Cardiol. 1996;3(4):350–5.

    CAS  PubMed  Google Scholar 

  53. Hendel RC, Wackers FJ, Berman DS, Ficaro E, Depuey EG, Klein L, et al. American society of nuclear cardiology consensus statement: reporting of radionuclide myocardial perfusion imaging studies. J Nucl Cardiol. 2003;10(6):705–8.

    PubMed  Google Scholar 

  54. Tragardh E, Hesse B, Knuuti J, Flotats A, Kaufmann PA, Kitsiou A, et al. Reporting nuclear cardiology: a joint position paper by the European Association of Nuclear Medicine (EANM) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2015;16(3):272–9.

    PubMed  Google Scholar 

  55. Tilkemeier PL, Bourque J, Doukky R, Sanghani R, Weinberg RL. ASNC imaging guidelines for nuclear cardiology procedures : standardized reporting of nuclear cardiology procedures. J Nucl Cardiol. 2017;24:2064.

    PubMed  Google Scholar 

  56. Iskandrian AE, Heo J, Nallamothu N. Detection of coronary artery disease in women with use of stress single-photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol. 1997;4(4):329–35.

    CAS  PubMed  Google Scholar 

  57. Mahmarian JJ, Boyce TM, Goldberg RK, Cocanougher MK, Roberts R, Verani MS. Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol. 1990;15(2):318–29.

    CAS  PubMed  Google Scholar 

  58. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA. 1998;280(10):913–20.

    CAS  PubMed  Google Scholar 

  59. Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging. 2012;5(6):700–7.

    PubMed  Google Scholar 

  60. Lee JM, Kim CH, Koo BK, Hwang D, Park J, Zhang J, et al. Integrated myocardial perfusion imaging diagnostics improve detection of functionally significant coronary artery stenosis by 13N-ammonia positron emission tomography. Circ Cardiovasc Imaging. 2016;9(9):pii: e004768.

    Google Scholar 

  61. Sciagra R, Passeri A, Bucerius J, Verberne HJ, Slart RH, Lindner O, et al. Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the cardiovascular Committee of the European Association of nuclear medicine (EANM). Eur J Nucl Med Mol Imaging. 2016;43(8):1530–45.

    PubMed  Google Scholar 

  62. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation appropriate use criteria task force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53(23):2201–29.

    PubMed  Google Scholar 

  63. Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.

    Google Scholar 

  64. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol. 2002;40(8):1531–40.

    PubMed  Google Scholar 

  65. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97(6):535–43.

    CAS  PubMed  Google Scholar 

  66. Shaw LJ, Hachamovitch R, Peterson ED, Lewin HC, Iskandrian AE, Miller DD, et al. Using an outcomes-based approach to identify candidates for risk stratification after exercise treadmill testing. J Gen Intern Med. 1999;14(1):1–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Gibbons RJ, Hodge DO, Berman DS, Akinboboye OO, Heo J, Hachamovitch R, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation. 1999;100(21):2140–5.

    CAS  PubMed  Google Scholar 

  68. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol. 2003;41(1):159–68.

    PubMed  Google Scholar 

  69. Akinboboye OO, Idris O, Onwuanyi A, Berekashvili K, Bergmann SR. Incidence of major cardiovascular events in black patients with normal myocardial stress perfusion study results. J Nucl Cardiol. 2001;8(5):541–7.

    CAS  PubMed  Google Scholar 

  70. Shaw LJ, Hendel RC, Cerquiera M, Mieres JH, Alazraki N, Krawczynska E, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;45(9):1494–504.

    PubMed  Google Scholar 

  71. Alkeylani A, Miller DD, Shaw LJ, Travin MI, Stratmann HG, Jenkins R, et al. Influence of race on the prediction of cardiac events with stress technetium-99m sestamibi tomographic imaging in patients with stable angina pectoris. Am J Cardiol. 1998;81(3):293–7.

    CAS  PubMed  Google Scholar 

  72. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, et al. Insights from the NHLBI-sponsored Women's ischemia syndrome evaluation (WISE) study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47(3 Suppl):S4–S20.

    PubMed  Google Scholar 

  73. Iskandar A, Limone B, Parker MW, Perugini A, Kim H, Jones C, et al. Gender differences in the diagnostic accuracy of SPECT myocardial perfusion imaging: a bivariate meta-analysis. J Nucl Cardiol. 2013;20(1):53–63.

    PubMed  Google Scholar 

  74. Phillips LM, Mieres JH. Noninvasive assessment of coronary artery disease in women: what’s next? Curr Cardiol Rep. 2010;12(2):147–54.

    PubMed  PubMed Central  Google Scholar 

  75. Patel MB, Bui LP, Kirkeeide RL, Gould KL. Imaging microvascular dysfunction and mechanisms for female-male differences in CAD. J Am Coll Cardiol Img. 2016;9(4):465–82.

    Google Scholar 

  76. Campisi R, Marengo FD. Coronary microvascular dysfunction in women with nonobstructive ischemic heart disease as assessed by positron emission tomography. Cardiovasc Diagn Ther. 2017;7(2):196–205.

    PubMed  PubMed Central  Google Scholar 

  77. Wagdy HM, Hodge D, Christian TF, Miller TD, Gibbons RJ. Prognostic value of vasodilator myocardial perfusion imaging in patients with left bundle-branch block. Circulation. 1998;97(16):1563–70.

    CAS  PubMed  Google Scholar 

  78. Gioia G, Bagheri B, Gottlieb CD, Schwartzman DS, Callans DJ, Marchlinski FE, et al. Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implantable cardioverter-defibrillators using SPECT perfusion imaging. Circulation. 1997;95(2):390–4.

    CAS  PubMed  Google Scholar 

  79. Amanullah AM, Berman DS, Kang X, Cohen I, Germano G, Friedman JD. Enhanced prognostic stratification of patients with left ventricular hypertrophy with the use of single-photon emission computed tomography. Am Heart J. 2000;140(3):456–62.

    CAS  PubMed  Google Scholar 

  80. Elhendy A, van Domburg RT, Sozzi FB, Poldermans D, Bax JJ, Roelandt JR. Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease. Heart. 2001;85(6):655–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Bartram P, Toft J, Hanel B, Ali S, Gustafsson F, Mortensen J, et al. False-positive defects in technetium-99m sestamibi myocardial single-photon emission tomography in healthy athletes with left ventricular hypertrophy. Eur J Nucl Med. 1998;25(9):1308–12.

    CAS  PubMed  Google Scholar 

  82. Blumenthal RS, Becker DM, Moy TF, Coresh J, Wilder LB, Becker LC. Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population. Circulation. 1996;93(5):915–23.

    CAS  PubMed  Google Scholar 

  83. Blumenthal RS, Becker DM, Yanek LR, Aversano TR, Moy TF, Kral BG, et al. Detecting occult coronary disease in a high-risk asymptomatic population. Circulation. 2003;107(5):702–7.

    PubMed  Google Scholar 

  84. American Diabetes Association. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation. 1999;100(10):1132–3.

    Google Scholar 

  85. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002;105(1):32–40.

    PubMed  Google Scholar 

  86. Kang X, Berman DS, Lewin H, Miranda R, Erel J, Friedman JD, et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J. 1999;137(5):949–57.

    CAS  PubMed  Google Scholar 

  87. Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J. 1999;138(6 Pt 1):1025–32.

    CAS  PubMed  Google Scholar 

  88. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27(8):1954–61.

    PubMed  Google Scholar 

  89. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15):1547–55.

    CAS  PubMed  PubMed Central  Google Scholar 

  90. Amsterdam EA, Kirk JD, Bluemke DA, Diercks D, Farkouh ME, Garvey JL, et al. Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. Circulation. 2010;122(17):1756–76.

    PubMed  PubMed Central  Google Scholar 

  91. Tatum JL, Jesse RL, Kontos MC, Nicholson CS, Schmidt KL, Roberts CS, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 1997;29(1):116–25.

    CAS  PubMed  Google Scholar 

  92. Heller GV, Stowers SA, Hendel RC, Herman SD, Daher E, Ahlberg AW, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol. 1998;31(5):1011–7.

    CAS  PubMed  Google Scholar 

  93. Udelson JE, Beshansky JR, Ballin DS, Feldman JA, Griffith JL, Handler J, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA. 2002;288(21):2693–700.

    PubMed  Google Scholar 

  94. Brown KA, Rowen M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol. 1993;71(10):865–7.

    CAS  PubMed  Google Scholar 

  95. Shaw LJ, Hachamovitch R, Berman DS, Marwick TH, Lauer MS, Heller GV, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of noninvasive diagnosis (END) multicenter study group. J Am Coll Cardiol. 1999;33(3):661–9.

    CAS  PubMed  Google Scholar 

  96. Brindis RG, Douglas PS, Hendel RC, Peterson ED, Wolk MJ, Allen JM, et al. ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation quality strategic directions committee appropriateness criteria working group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol. 2005;46(8):1587–605.

    PubMed  Google Scholar 

  97. McPherson JA, Robinson PS, Powers ER, Sarembock IJ, Gimple LW, Ragosta M. Angiographic findings in patients undergoing catheterization for recurrent symptoms within 30 days of successful coronary intervention. Am J Cardiol. 1999;84(5):589–92. A8

    CAS  PubMed  Google Scholar 

  98. Jain A, Mahmarian JJ, Borges-Neto S, Johnston DL, Cashion WR, Lewis JM, et al. Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty. J Am Coll Cardiol. 1988;11(5):970–6.

    CAS  PubMed  Google Scholar 

  99. Ho KT, Miller TD, Holmes DR, Hodge DO, Gibbons RJ. Long-term prognostic value of Duke treadmill score and exercise thallium-201 imaging performed one to three years after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1999;84(11):1323–7.

    CAS  PubMed  Google Scholar 

  100. Hamilos MI, Ostojic M, Beleslin B, Sagic D, Mangovski L, Stojkovic S, et al. Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. J Am Coll Cardiol. 2008;51(22):2123–9.

    CAS  PubMed  Google Scholar 

  101. Ertas G, van Beusekom HM, van der Giessen WJ. Late stent thrombosis, endothelialisation and drug-eluting stents. Netherlands Jeart J. 2009;17(4):177–80.

    CAS  Google Scholar 

  102. Miller TD, Christian TF, Hodge DO, Mullan BP, Gibbons RJ. Prognostic value of exercise thallium-201 imaging performed within 2 years of coronary artery bypass graft surgery. J Am Coll Cardiol. 1998;31(4):848–54.

    CAS  PubMed  Google Scholar 

  103. Palmas W, Bingham S, Diamond GA, Denton TA, Kiat H, Friedman JD, et al. Incremental prognostic value of exercise thallium-201 myocardial single-photon emission computed tomography late after coronary artery bypass surgery. J Am Coll Cardiol. 1995;25(2):403–9.

    CAS  PubMed  Google Scholar 

  104. Zellweger MJ, Lewin HC, Lai S, Dubois EA, Friedman JD, Germano G, et al. When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of appropriate clinical strategies. J Am Coll Cardiol. 2001;37(1):144–52.

    CAS  PubMed  Google Scholar 

  105. Lauer MS, Lytle B, Pashkow F, Snader CE, Marwick TH. Prediction of death and myocardial infarction by screening with exercise-thallium testing after coronary-artery-bypass grafting. Lancet. 1998;351(9103):615–22.

    CAS  PubMed  Google Scholar 

  106. Nallamothu N, Johnson JH, Bagheri B, Heo J, Iskandrian AE. Utility of stress single-photon emission computed tomography (SPECT) perfusion imaging in predicting outcome after coronary artery bypass grafting. Am J Cardiol. 1997;80(12):1517–21.

    CAS  PubMed  Google Scholar 

  107. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). J Am Coll Cardiol. 2002;39(3):542–53.

    PubMed  Google Scholar 

  108. Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med. 1995;333(26):1750–6.

    CAS  PubMed  Google Scholar 

  109. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Developed in collaboration with the American College of Surgeons, American Society of Anesthesiologists, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists, and Society of Vascular Medicine Endorsed by the Society of Hospital Medicine. J Nucl Cardiol. 2015;22(1):162–215.

    PubMed  Google Scholar 

  110. Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, Hert SD, et al. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383–431.

    Google Scholar 

  111. Rahimtoola SH. Chronic myocardial hibernation. Circulation. 1994;89(4):1907–8.

    CAS  PubMed  Google Scholar 

  112. Patel H, Mazur W, Williams KA Sr, Kalra DK. Myocardial viability-state of the art: is it still relevant and how to best assess it with imaging? Trends Cardiovasc Med. 2018;28(1):24–37.

    PubMed  Google Scholar 

  113. Acampa W, Cuocolo A, Petretta M, Bruno A, Castellani M, Finzi A, et al. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy. J Nucl Cardiol. 2002;9(1):33–40.

    PubMed  Google Scholar 

  114. Orlandini A, Castellana N, Pascual A, Botto F, Cecilia Bahit M, Chacon C, et al. Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: a meta-analysis of non-randomized and randomized studies. Int J Cardiol. 2015;182:494–9.

    PubMed  Google Scholar 

  115. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73(8):527–33.

    PubMed  Google Scholar 

  116. Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 1995;92(12):3436–44.

    PubMed  Google Scholar 

  117. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39(7):1151–8.

    PubMed  Google Scholar 

  118. Beanlands RS, Ruddy TD, de Kemp RA, Iwanochko RM, Coates G, Freeman M, et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol. 2002;40(10):1735–43.

    PubMed  Google Scholar 

  119. D'Egidio G, Nichol G, Williams KA, Guo A, Garrard L, de Kemp RA, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. J Am Coll Cardiol Img. 2009;2(9):1060–8.

    Google Scholar 

  120. Hesse B, Lindhardt TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, et al. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging. 2008;35(4):851–85.

    CAS  PubMed  Google Scholar 

  121. Gibbons RJ. Rest and exercise radionuclide angiography for diagnosis in chronic ischemic heart disease. Circulation. 1991;84(3 Suppl):I93–9.

    CAS  PubMed  Google Scholar 

  122. Schwartz RG, McKenzie WB, Alexander J, Sager P, D'Souza A, Manatunga A, et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med. 1987;82(6):1109–18.

    CAS  PubMed  Google Scholar 

  123. Schwartz RG, Jain D, Storozynsky E. Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively. J Nucl Cardiol. 2013;20(3):443–64.

    PubMed  Google Scholar 

  124. Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768–801.

    PubMed  Google Scholar 

  125. Bloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, et al. Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging. Circ Heart Fail. 2016;9(1):e002661.

    PubMed  PubMed Central  Google Scholar 

  126. Hamo CE, Bloom MW, Cardinale D, Ky B, Nohria A, Baer L, et al. Cancer therapy-related cardiac dysfunction and heart failure: part 2: prevention, treatment, guidelines, and future directions. Circ Heart Fail. 2016;9(2):e002843.

    CAS  PubMed  PubMed Central  Google Scholar 

  127. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29(9):1147–59.

    PubMed  Google Scholar 

  128. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol. 2010;55(20):2212–21.

    PubMed  Google Scholar 

  129. Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL Jr, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63(2):141–9.

    PubMed  Google Scholar 

  130. Bejar D, Colombo PC, Latif F, Yuzefpolskaya M. Infiltrative cardiomyopathies. Clin Med Insights Cardiol. 2015;9(Suppl 2):29–38.

    CAS  PubMed  PubMed Central  Google Scholar 

  131. Juneau D, Erthal F, Alzahrani A, Alenazy A, Nery PB, Beanlands RS, et al. Systemic and inflammatory disorders involving the heart: the role of PET imaging. Q J Nucl Med Mol Imaging. 2016;60(4):383–96.

    PubMed  Google Scholar 

  132. Erthal F, Juneau D, Lim SP, Dwivedi G, Nery PB, Birnie D, et al. Imaging of cardiac sarcoidosis. Q J Nucl Med Mol Imaging. 2016;60(3):252–63.

    PubMed  Google Scholar 

  133. Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. J Nucl Cardiol. 2017;24(2):413–24.

    PubMed  Google Scholar 

  134. Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017;24:1741.

    PubMed  Google Scholar 

  135. Bokhari S, Shahzad R, Castano A, Maurer MS. Nuclear imaging modalities for cardiac amyloidosis. J Nucl Cardiol. 2014;21(1):175–84.

    PubMed  PubMed Central  Google Scholar 

  136. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128.

    PubMed  Google Scholar 

  137. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and Management of Complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–86.

    CAS  PubMed  Google Scholar 

  138. Gomes A, Glaudemans A, Touw DJ, van Melle JP, Willems TP, Maass AH, et al. Diagnostic value of imaging in infective endocarditis: a systematic review. Lancet Infect Dis. 2017;17(1):e1–e14.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Coimbra Hospital and University Center, University of Coimbra, Coimbra, Portugal

    Maria João Vidigal Ferreira

  2. Department of Nuclear Medicine, Cleveland Clinic, Cleveland, OH, USA

    Manuel D. Cerqueira

  3. Cleveland Clinic Lerner College of Medicine, Of Case Western Reserve University, Cleveland, OH, USA

    Manuel D. Cerqueira

Authors
  1. Maria João Vidigal Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manuel D. Cerqueira
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manuel D. Cerqueira .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Klinikum Westfalen - Knappschaftskrankenhaus Academic teaching hospital of the Ruhr University, Dortmund, Nordrhein-Westfalen, Germany

    Hojjat Ahmadzadehfar

  2. Department of Nuclear Medicine, Beta Klinik Bonn, Bonn, Germany

    Hans-Jürgen Biersack

  3. Division of Nuclear Medicine, Department of Radiology, Montefiore Medical Center, Bronx, NY, USA

    Leonard M. Freeman

  4. Albert Einstein College of Medicine, Bronx, NY, USA

    Lionel S. Zuckier

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ferreira, M.J.V., Cerqueira, M.D. (2020). Clinical Applications of Nuclear Cardiology. In: Ahmadzadehfar, H., Biersack, HJ., Freeman, L., Zuckier, L. (eds) Clinical Nuclear Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-39457-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-39457-8_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-39455-4

  • Online ISBN: 978-3-030-39457-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation